Can aflatoxin B1, nivalenol, and trichothecenes trigger inflammation and oxidative stress?

Exposure to environmental mycotoxins represents a potent trigger for systemic physiological dysfunction. Research demonstrates that aflatoxin B1, nivalenol, and macrocyclic trichothecenes directly initiate cascading cellular stress that manifests as complex, multi-system symptoms.

Mechanistic pathways of toxicity

• Oxidative and Mitochondrial Stress: Aflatoxin B1, nivalenol, and trichothecenes (such as verrucarin J) cause direct cellular damage by generating reactive oxygen species (ROS), depleting glutathione, and inducing lipid peroxidation. This damage diminishes mitochondrial membrane potential and compromises ATP production.
• Inflammatory Cascades: These oxidative triggers activate downstream signaling via NF-κB and the NLRP3 inflammasome. This leads to the robust transcription and release of key pro-inflammatory cytokines, including TNF-α, IL-1β, IL-6, and IL-18.

Systemic physiological consequences

• Fatigue and Energy Depletion: The depletion of cellular energy reserves and mitochondrial dysfunction driven by these mycotoxins directly correlate with severe, chronic fatigue and exercise intolerance.
• Immune Dysregulation: Chronic systemic inflammation alters T-cell balance, disrupts natural killer cell activity, and impairs regulatory pathways, leaving peripheral blood mononuclear cells in a chronically primed, dysfunctional state.
• Central Pain Sensitization: These mycotoxins cross the blood-brain barrier to trigger neuroinflammation by activating microglia and astrocytes. Activated glia release mediators like IL-1β, TNF-α, and BDNF, which modulate nociceptive neurons, alter synaptic plasticity, and cause widespread pain, hyperalgesia, and allodynia.

Bottom line

• Exposure to aflatoxin B1, nivalenol, and trichothecenes drives a clear pathological cascade of mitochondrial decay, glial activation, and chronic neuroinflammation. This network of pathways directly explains the clinical presentation of chronic fatigue, systemic immune dysregulation, and heightened pain sensitivity.